This concise consultation card was developed by Guidelines for Pharmacy in partnership with Reckitt.
Essential information and adverse reporting details are included.
RB-M-48255 October 2021
The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)
This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/MKT/RZM/20-0029f October 2020